New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

33

U.S. FDA Accepts for Priority Review Pfizer’s Application for TicoVac

The U.S. Food and Drug Administration accepted for Priority Review Pfizer Inc.’s Biologics License Application for TicoVac, the company’s tick-borne encephalitis vaccine for active immunization to prevent TBE in individuals 1 year of age and older.

34

Covid-19 Vaccine Maker Clover Raises $230 Million in Series C Round

Clover Biopharmaceuticals raised a $230 million series C round co-led by GL Ventures and Temasek, which will push the Chinese fusion protein company’s Covid-19 vaccine into Phase II/III testing and production planning.

36

70% Drop in Covid-19 Cases in UK Analyses After Just One Pfizer Shot

Public Health England (PHE) published real-world analyses of people in the U.K. who had received the first shot of the Pfizer-BioNTech Covid-19 vaccine, with the data – which were published in The Lancet – showing that there was a decrease of about 70 percent in infections among healthcare workers after the first shot.

37

FDA Plans Ahead for Covid-19 Mutations with Booster Shot Guidance

The U.S. Food and Drug Administration issued new guidance for vaccine makers as the regulatory agency is preparing for the possibility of needing to approve Covid-19 booster shots against variants of the SARS-CoV-2 virus.

38

FDA to allow Pfizer-BioNTech vaccine to be stored at higher temps: NYT

FDA to allow Pfizer-BioNTech vaccine to be stored at higher temps: NYT (Reuters) – The U.S. Food & Drug Administration plans to approve Pfizer Inc and BioNTech SE’s request to store their COVID-19 vaccine at standard freezer temperatures instead of in ultra-cold conditions, the New York Times reported on Tuesday. The FDA is expected to […]

39

Regeneron and Sanofi Collaboration Receives Third FDA Drug Approval

Regeneron and Sanofi’s checkpoint inhibitor Libtayo (cemiplimab-rwlc) won U.S. Food and Drug Administration approval for the first-line treatment of patients with advanced non-small cell lung cancer whose tumors have high PD-L1 expression.

40

Fauci says he sees U.S. CDC relaxing some COVID-19 guidelines soon: CNN

Top U.S. infectious disease official Anthony Fauci on Feb. 23 told CNN that he expects the U.S. Centers for Disease Control and Prevention to soon relax some Covid-19 recommendations aimed at curbing its spread for people who have been vaccinated.